dc.contributor.author | Coskun, Raif | |
dc.contributor.author | Gelincik, Aslı | |
dc.contributor.author | Unal, Derya | |
dc.contributor.author | Buyukozturk, Suna | |
dc.contributor.author | Colakoglu, Bahauddin | |
dc.contributor.author | Demir, SEMRA | |
dc.contributor.author | Olgac, Muge | |
dc.date.accessioned | 2021-03-04T11:09:03Z | |
dc.date.available | 2021-03-04T11:09:03Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Demir S., Olgac M., Unal D., Coskun R., Gelincik A., Colakoglu B., Buyukozturk S., "Opinions of Turkish Hereditary Angioedema Patients Regarding the Use of C1 Inhibitor Concentrate in the Treatment of Acute Attacks", ASTIM ALLERJI IMMUNOLOJI, cilt.17, sa.1, ss.47-52, 2019 | |
dc.identifier.other | av_70d45865-1023-4fb7-b002-0485f460463e | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/77766 | |
dc.identifier.uri | https://doi.org/10.21911/aai.439 | |
dc.description.abstract | Objective: No data exists about the perceptions of Turkish hereditary angioedema patients regarding the use of C1 inhibitor concentrate that has been used in the treatment of acute attacks for the last 7 years. Our aim was to evaluate patient opinions about the C1 inhibitor (C1-inh) concentrate and determine the level of satisfaction with this drug. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | ALERJİ | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.title | Opinions of Turkish Hereditary Angioedema Patients Regarding the Use of C1 Inhibitor Concentrate in the Treatment of Acute Attacks | |
dc.type | Makale | |
dc.relation.journal | ASTIM ALLERJI IMMUNOLOJI | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 17 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 47 | |
dc.identifier.endpage | 52 | |
dc.contributor.firstauthorID | 83682 | |